| Novo Nordisk Pharma AG - Xultophy Insulin Degludec 100 E/ml und Liraglutide 3.6 mg/ml, Injektionslösung |
| 65041 | | 01 | | Xultophy Insulin Degludec 100 E/ml und Liraglutide 3.6 mg/ml | | Injektionslösung | | A10AE56 | | Insulin Degludec and Liraglutide | | 12.09.2014 | | |
|
| Composition |
| insulinum degludecum 600 nmol corresp. insulinum degludecum 100 U., liraglutidum 3.6 mg, phenolum, glycerolum, zincum ut zinci acetas dihydricus, acidum hydrochloridum, natrii hydroxidum corresp. natrium max. 0.0416 mmol, aqua ad iniectabile q.s. ad solutionem pro 1 ml. |
| Packungsbestandteile |
| Injection solution | | | | | | | | Active Agent | Dose |
|---|
| Insulinum Degludecum | 600 | | Liraglutidum | 3.6 mg/ml | | Nmol | |
| | BAG: Active Agent | Dose |
|---|
| Insulinum Degludecum | 100 U | | Liraglutidum | 3.6 mg |
| | | | Inactive agents |
|---|
| Acidum Hydrochloridum | | Glycerol | | Sodium Hydroxide | | Phenol | | Zincum |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 005 | 3 x 3 ml | 116.91 | 143.55 | B | SL | Yes |
|
